Market Place
Sourcing Support
Manufacturing and Marketing Approval for Three Ingredients and Eight Items
15 Feb 2024 //
PRESS RELEASE
Amdipharm`s Zonegran Receives Approval in Europe
09 Dec 2022 //
EMA
Eton Pharma Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension)
18 Jul 2022 //
GLOBENEWSWIRE
AZURITY PHARMA ANNOUNCES FDA APPROVAL OF ZONISADE (zonisamide oral suspension)
18 Jul 2022 //
PRNEWSWIRE
Enforcement Report - Week of May 4, 2022
04 May 2022 //
FDA
Enforcement Report - Week of September 29, 2021
29 Sep 2021 //
FDA
Eisai to divest rights for antiepileptic agent Zonegran to Advanz Pharma
15 Jun 2021 //
PHARMABIZ
Unichem Labs Generic Zonisamide Receives Approval in US
29 Jan 2021 //
FDA
Eton Submits New Drug Application to the FDA for Zonisamide (ET-104)
30 Jul 2020 //
GLOBENEWSWIRE
Six medicines line up for EU approval
01 Feb 2016 //
PHARMATIMES
Presented new data, the use of Zebinix to treat partial onset seizure at AES
09 Dec 2015 //
PR NEWS WIRE
Zebinix® (eslicarbazepine acetate) in the treatment of partial seizures
07 Dec 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.